Evidence map›Paper›PMID 35873489›Full record

ArticleFrontiers in genetics2022

Identical

Joanna Walczak-Sztulpa, Anna Wawrocka, Cenna Doornbos, Ronald van Beek, Anna Sowińska-Seidler, Aleksander Jamsheer, Ewelina Bukowska-Olech, Anna Latos-Bieleńska, Ryszard Grenda, Ernie M H F Bongers and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07356466 (Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07356466 early_phase1enrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A Single-Center Randomized Controlled Trial

TypeinterventionalSponsorFujian Medical UniversityRan2025 to 2030Enrolled100ConditionsGastric (Stomach) CancerArmsPucotenlimab Combined with Lenvatinib, Oxaliplatin plus S-1 regimen
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Ciliary-Mediated Mechanotransduction in Skeletal Development and Diseases.Results and problems in cell differentiation · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Joanna Walczak-SztulpaDepartment of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland.
Anna WawrockaDepartment of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland.
Cenna DoornbosDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
Ronald van BeekDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
Anna Sowińska-SeidlerDepartment of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland.
Aleksander JamsheerDepartment of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland.
Ewelina Bukowska-OlechDepartment of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland.
Anna Latos-BieleńskaDepartment of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland.
Ryszard GrendaDepartment of Nephrology, Kidney Transplantation and Hypertension, The Children's Memorial Health Institute, Warsaw, Poland.
Ernie M H F BongersDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
Miriam SchmidtsCenter for Pediatrics and Adolescent Medicine, University Hospital Freiburg, Freiburg University Faculty of Medicine, Freiburg, Germany.
Ewa ObersztynDepartment of Medical Genetics, Institute of Mother and Child, Warsaw, Poland.
Maciej R KrawczyńskiDepartment of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland.
Machteld M OudDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
Poznan University of Medical Sciences · PLRadboud University Nijmegen · NLChildren's Memorial Health Institute · PLRadboud University Medical Center · NLUniversity Medical Center Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ciliopathies are rare congenital disorders, caused by defects in the cilium, that cover a broad clinical spectrum. A subgroup of ciliopathies showing significant phenotypic overlap are known as skeletal ciliopathies and include Jeune asphyxiating thoracic dysplasia (JATD), Mainzer-Saldino syndrome (MZSDS), cranioectodermal dysplasia (CED), and short-rib polydactyly (SRP). Ciliopathies are heterogeneous disorders with >187 associated genes, of which some genes are described to cause more than one ciliopathy phenotype. Both the clinical and molecular overlap make accurate diagnosing of these disorders challenging. We describe two unrelated Polish patients presenting with a skeletal ciliopathy who share the same compound heterozygous variants in

Indexed as

CED-like featurescilium phenotypeIFT140MZSDS-like featuresskeletal ciliopathy

Identifiers

PMID35873489
PMCPMC9300986
OpenAlexW4284900129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.